Search Results for 'Patients-Trastuzumab'

Patients-Trastuzumab published presentations and documents on DocSlides.

Eribulin   Mesylate  +  Trastuzumab
Eribulin Mesylate + Trastuzumab
by easyho
as First-Line Therapy for Locally Recurrent or . M...
Breast Cancer in Older Patients
Breast Cancer in Older Patients
by ButterflyKisses
Key Issues. Etienne GC . Brain. , MD . PhD. Instit...
Fast relapsing
Fast relapsing
by danika-pritchard
patients . i.e. Patient relapses during or within...
Mauricio Lema Medina  – Clínica de Oncología Astorga / Clínica SOMA, Medellín
Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín
by delcy
Trastuzumab-emtansine. : A . very. . nice. . poi...
Module 9:  HER2-Positive and Triple-Negative BC
Module 9: HER2-Positive and Triple-Negative BC
by unita
Percent with Patients. Number of Patients (Median)...
Risk of Heart Failure in Breast Cancer Patients After
Risk of Heart Failure in Breast Cancer Patients After
by sophia2
Anthracycline. and . Trastuzumab. Treatment: A R...
Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use
Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use
by gelbero
Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...
Cost Impact Of Biosimiliars in Oncology
Cost Impact Of Biosimiliars in Oncology
by williams
Mansoor A Khan, BS, MS, BCOP. Senior Clinical Phar...
Budget impact and cost-effectiveness of oncology
Budget impact and cost-effectiveness of oncology
by roxanne
biosimilars. Prof. dr. Steven Simoens. Health econ...
Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer
Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer
by faustina-dinatale
Dr. . Khaled Abulkhair, PhD. Medical Oncology SCE...
William J.
William J.
by tawny-fly
Gradishar. . MD, FACP. Betsy . Bramsen. Profess...
Metastatic HER2-Positive Breast Cancer: Treatment Selection
Metastatic HER2-Positive Breast Cancer: Treatment Selection
by test
First . Line and Beyond. Moderator:. Joseph Gligo...
Her2 + Breast Cancer Laura
Her2 + Breast Cancer Laura
by ximena
Bidstrup. Mrs B is a 49 . yo. woman who attended ...
Part B Medical Drugs Requiring StepTherapy
Part B Medical Drugs Requiring StepTherapy
by natalie
Drug subject to Step Therapy BRAND NAME GENERIC NA...
Part B Medical Drugs Requiring Step
Part B Medical Drugs Requiring Step
by udeline
-TherapyDrug subject to Step TherapyTry these Opti...
Module 9: HER2-Positive and
Module 9: HER2-Positive and
by norah
Triple-Negative Breast Cancer. Jamie Carroll, APRN...
Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings
Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings
by marina-yarberry
Management of HER2 Over-Expressed Breast Cancer i...
Antibody–Drug Conjugates in Development for Non-
Antibody–Drug Conjugates in Development for Non-
by elizabeth
s. mall Cell . Lung Cancer. , Gastric Cancer, and ...
update  in                              metastatic breast c
update in metastatic breast c
by min-jolicoeur
. Dr.Mina. . Tajvidi. Radiation . oncologist. ...
Metastatic  triple-positive
Metastatic triple-positive
by marcos147
breast. . cancer. . needs. . different. . ther...
Antibody–Drug Conjugates
Antibody–Drug Conjugates
by wang
in Development for . Breast Cancer. Sara A. Hurvit...
Dawid Sigorski,  Ph.D  .
Dawid Sigorski, Ph.D .
by morgan
Department. of . oncology. . UWM. Epidemiology. ...
Systemic  Therapy for Breast Cancer
Systemic Therapy for Breast Cancer
by natalia-silvester
Adjuvant or Neoadjuvant. Agustin A Garcia, MD, MM...
Breast Cancer Highlights From San Antonio
Breast Cancer Highlights From San Antonio
by tatyana-admore
Joyce O'Shaughnessy, MD. Kimberly Blackwell, MD. ...
Managing Breast Cancer in the Genomic Era
Managing Breast Cancer in the Genomic Era
by alida-meadow
Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...
New Therapies for Metastatic Breast Cancer
New Therapies for Metastatic Breast Cancer
by alexa-scheidler
Sigrun Hallmeyer, MD. Oncology Specialists, SC. D...
GIULIANA  D’AURIA UOC Oncologia ASL Roma 2
GIULIANA D’AURIA UOC Oncologia ASL Roma 2
by hadley
Osp. . Pertini-S.Eugenio-CTO. Therapeutic. . app...
Istituto Toscano Tumori –Livorno, Italy
Istituto Toscano Tumori –Livorno, Italy
by payton
Federico . Cappuzzo. Istituto Toscano Tumori. Ospe...
Advanced Breast Cancer 31 year old female px  severe pain right UL ‘burning’ pain
Advanced Breast Cancer 31 year old female px severe pain right UL ‘burning’ pain
by margaret
Background of lower back pain for 3/12 . No past ...
CoclusteringofErbB1andErbB2RevealedbyFRETSensitizedAcceptorBleachingg
CoclusteringofErbB1andErbB2RevealedbyFRETSensitizedAcceptorBleachingg
by cora
SubmittedDecember10,2009,andacceptedforpublication...
DRUG NAMES AND MEDICATION ERRORS
DRUG NAMES AND MEDICATION ERRORS
by freya
1. DRUG NAMES. Chemical name. Development name use...
Updates in the Treatment of Breast cancer
Updates in the Treatment of Breast cancer
by alexa-scheidler
Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...
ID DB06366 						 CATEGORY
ID DB06366 CATEGORY
by luanne-stotts
Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...
MUGA scans
MUGA scans
by danika-pritchard
&. monitoring of chemotherapy. Cardiovascular...
Table Stock Incidence Malaysia Dialysis Patients Patients
Table Stock Incidence Malaysia Dialysis Patients Patients
by reece880
Sunita Bavanandan. Hooi Lai Seong. Ong Loke Meng. ...
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
by GratefulHeart
Akhtar . Fajar. . Muzakkir. New ESC NSTEMI Guidel...
Immunizing Adult Patients  Standards for PracticeYour patients trust y
Immunizing Adult Patients Standards for PracticeYour patients trust y
by payton
received all the vaccines they needEven though mos...